Improving the preclinical models for the study of chemotherapy-induced cardiotoxicity: a Position Paper of the Italian Working Group on Drug Cardiotoxicity and Cardioprotection

Verfasser / Beitragende:
[Rosalinda Madonna, Christian Cadeddu, Martino Deidda, Donato Mele, Ines Monte, Giuseppina Novo, Pasquale Pagliaro, Alessia Pepe, Paolo Spallarossa, Carlo Tocchetti, Concetta Zito, Giuseppe Mercuro]
Ort, Verlag, Jahr:
2015
Enthalten in:
Heart Failure Reviews, 20/5(2015-09-01), 621-631
Format:
Artikel (online)
ID: 605479119
LEADER caa a22 4500
001 605479119
003 CHVBK
005 20210128100408.0
007 cr unu---uuuuu
008 210128e20150901xx s 000 0 eng
024 7 0 |a 10.1007/s10741-015-9497-4  |2 doi 
035 |a (NATIONALLICENCE)springer-10.1007/s10741-015-9497-4 
245 0 0 |a Improving the preclinical models for the study of chemotherapy-induced cardiotoxicity: a Position Paper of the Italian Working Group on Drug Cardiotoxicity and Cardioprotection  |h [Elektronische Daten]  |c [Rosalinda Madonna, Christian Cadeddu, Martino Deidda, Donato Mele, Ines Monte, Giuseppina Novo, Pasquale Pagliaro, Alessia Pepe, Paolo Spallarossa, Carlo Tocchetti, Concetta Zito, Giuseppe Mercuro] 
520 3 |a Although treatment for heart failure induced by cancer therapy has improved in recent years, the prevalence of cardiomyopathy due to antineoplastic therapy remains significant worldwide. In addition to traditional mediators of myocardial damage, such as reactive oxygen species, new pathways and target cells should be considered responsible for the impairment of cardiac function during anticancer treatment. Accordingly, there is a need to develop novel therapeutic strategies to protect the heart from pharmacologic injury, and improve clinical outcomes in cancer patients. The development of novel protective therapies requires testing putative therapeutic strategies in appropriate animal models of chemotherapy-induced cardiomyopathy. This Position Paper of the Working Group on Drug Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology aims to: (1) define the distinctive etiopatogenetic features of cardiac toxicity induced by cancer therapy in humans, which include new aspects of mitochondrial function and oxidative stress, neuregulin-1 modulation through the ErbB receptor family, angiogenesis inhibition, and cardiac stem cell depletion and/or dysfunction; (2) review the new, more promising therapeutic strategies for cardioprotection, aimed to increase the survival of patients with severe antineoplastic-induced cardiotoxicity; (3) recommend the distinctive pathological features of cardiotoxicity induced by cancer therapy in humans that should be present in animal models used to identify or to test new cardioprotective therapies. 
540 |a Springer Science+Business Media New York, 2015 
690 7 |a Cancer therapy-induced cardiac injury  |2 nationallicence 
690 7 |a Preclinical models  |2 nationallicence 
690 7 |a Cardioprotection  |2 nationallicence 
690 7 |a Mitochondria  |2 nationallicence 
690 7 |a Neuregulin-1  |2 nationallicence 
690 7 |a Oxidative stress  |2 nationallicence 
690 7 |a Statins  |2 nationallicence 
690 7 |a Beta-blockers  |2 nationallicence 
690 7 |a ACE inhibitors  |2 nationallicence 
690 7 |a Cardiac stem cells  |2 nationallicence 
690 7 |a CHF : Congestive heart failure  |2 nationallicence 
690 7 |a ROS : Reactive oxygen species  |2 nationallicence 
690 7 |a NRG-1 : Neuregulin-1  |2 nationallicence 
690 7 |a Top2 : Topoisomerase II  |2 nationallicence 
690 7 |a PI3 : Phosphoinositide-3  |2 nationallicence 
690 7 |a AKT : Protein kinase B  |2 nationallicence 
690 7 |a MEK/ERK : Mitogen extracellular kinase  |2 nationallicence 
690 7 |a TK : Tyrosine kinase  |2 nationallicence 
690 7 |a VEGFR : Vascular endothelial growth factor receptor  |2 nationallicence 
690 7 |a PDGFR : Platelet-derived growth factor receptor  |2 nationallicence 
690 7 |a CSCs : Cardiac stem cells  |2 nationallicence 
690 7 |a CPCs : Cardiac progenitor cells  |2 nationallicence 
690 7 |a ACE : Angiotensin-converting enzyme  |2 nationallicence 
700 1 |a Madonna  |D Rosalinda  |u Center of Excellence on Aging, Institute of Cardiology, "G. d'Annunzio” University - Chieti, Chieti, Italy  |4 aut 
700 1 |a Cadeddu  |D Christian  |u Department of Medical Sciences "Mario Aresu”, University of Cagliari, Cagliari, Italy  |4 aut 
700 1 |a Deidda  |D Martino  |u Department of Medical Sciences "Mario Aresu”, University of Cagliari, Cagliari, Italy  |4 aut 
700 1 |a Mele  |D Donato  |u Cardiology Unit, University Hospital of Ferrara, Ferrara, Italy  |4 aut 
700 1 |a Monte  |D Ines  |u Department of General Surgery and Medical-Surgery Specialties, University of Catania, Catania, Italy  |4 aut 
700 1 |a Novo  |D Giuseppina  |u Chair and Division of Cardiology, University of Palermo, Palermo, Italy  |4 aut 
700 1 |a Pagliaro  |D Pasquale  |u Department of Clinical and Biological Sciences, University of Turin, Orbassano, Italy  |4 aut 
700 1 |a Pepe  |D Alessia  |u U.O.C. Magnetic Resonance Imaging, Fondazione G. Monasterio C.N.R., Pisa, Italy  |4 aut 
700 1 |a Spallarossa  |D Paolo  |u Clinic of Cardiovascular Diseases, IRCCS San Martino IST, Genoa, Italy  |4 aut 
700 1 |a Tocchetti  |D Carlo  |u Division of Internal Medicine, Department of Translational Medical Sciences, Federico II University, Naples, Italy  |4 aut 
700 1 |a Zito  |D Concetta  |u U.O.C. Cardiology Intensive Unit, A.O.U. Policlinico "G. Martino”, University of Messina, Messina, Italy  |4 aut 
700 1 |a Mercuro  |D Giuseppe  |u Department of Medical Sciences "Mario Aresu”, University of Cagliari, Cagliari, Italy  |4 aut 
773 0 |t Heart Failure Reviews  |d Springer US; http://www.springer-ny.com  |g 20/5(2015-09-01), 621-631  |x 1382-4147  |q 20:5<621  |1 2015  |2 20  |o 10741 
856 4 0 |u https://doi.org/10.1007/s10741-015-9497-4  |q text/html  |z Onlinezugriff via DOI 
898 |a BK010053  |b XK010053  |c XK010000 
900 7 |a Metadata rights reserved  |b Springer special CC-BY-NC licence  |2 nationallicence 
908 |D 1  |a research-article  |2 jats 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-springer 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1007/s10741-015-9497-4  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Madonna  |D Rosalinda  |u Center of Excellence on Aging, Institute of Cardiology, "G. d'Annunzio” University - Chieti, Chieti, Italy  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Cadeddu  |D Christian  |u Department of Medical Sciences "Mario Aresu”, University of Cagliari, Cagliari, Italy  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Deidda  |D Martino  |u Department of Medical Sciences "Mario Aresu”, University of Cagliari, Cagliari, Italy  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Mele  |D Donato  |u Cardiology Unit, University Hospital of Ferrara, Ferrara, Italy  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Monte  |D Ines  |u Department of General Surgery and Medical-Surgery Specialties, University of Catania, Catania, Italy  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Novo  |D Giuseppina  |u Chair and Division of Cardiology, University of Palermo, Palermo, Italy  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Pagliaro  |D Pasquale  |u Department of Clinical and Biological Sciences, University of Turin, Orbassano, Italy  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Pepe  |D Alessia  |u U.O.C. Magnetic Resonance Imaging, Fondazione G. Monasterio C.N.R., Pisa, Italy  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Spallarossa  |D Paolo  |u Clinic of Cardiovascular Diseases, IRCCS San Martino IST, Genoa, Italy  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Tocchetti  |D Carlo  |u Division of Internal Medicine, Department of Translational Medical Sciences, Federico II University, Naples, Italy  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Zito  |D Concetta  |u U.O.C. Cardiology Intensive Unit, A.O.U. Policlinico "G. Martino”, University of Messina, Messina, Italy  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Mercuro  |D Giuseppe  |u Department of Medical Sciences "Mario Aresu”, University of Cagliari, Cagliari, Italy  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t Heart Failure Reviews  |d Springer US; http://www.springer-ny.com  |g 20/5(2015-09-01), 621-631  |x 1382-4147  |q 20:5<621  |1 2015  |2 20  |o 10741